Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objectives: Incidental cerebral microhemorrhage (MH) is frequently found in older individuals scanned with susceptibility-weighted MRI (SWI) or gradient-recalled echo MRI. MH have been linked with β-amyloid (Aβ) deposition using 11C-Pittsburgh compound B (PiB) PET in Alzheimer disease (AD) and cerebral amyloid angiopathy (CAA). We hypothesized that Aβ deposition in asymptomatic elderly individuals is associated with lobar MH (LMH).
Methods: This was a cross-sectional study of 84 elderly healthy controls (HC), 28 subjects with mild cognitive impairment (MCI), and 26 subjects with probable AD who underwent 3-T SWI and 11C-PiB PET. 11C-PiB cortical binding was quantified normalized to cerebellar cortex (standardized uptake value ratio [SUVR]) and scans classified as positive (PiB+) or negative (PiB−) by visual inspection. MH were manually counted and categorized by region and as lobar or nonlobar.
Results: LMH were present in 30.8% of AD, 35.7% of MCI, and 19.1% of HC. The prevalence of LMH among PiB+ subjects was similar, regardless of clinical classification (AD 30.8%, MCI 38.9%, HC 41.4%, p > 0.7). HC with LMH had significantly higher mean neocortical SUVR (1.7 ± 0.5) than HC without LMH (1.3 ± 0.3, p ± 0.01). In HC, there was a positive correlation between number of LMH and SUVR, and between LMH and age. In HC, PiB+ (odds ratio [OR] 7.3, 95% confidence interval [CI] 1.6–33.7, p = 0.01) and age (OR 1.2, 95% CI 1.03–1.3, p = 0.02) both independently predicted the occurrence of LMH using logistic regression.
Conclusion: Asymptomatic Aβ deposition in older adults is strongly associated with LMH.
Footnotes
Study funding: Supported by CSIRO and National Health and Medical Research Council Dementia Collaborative Research Centres Early Diagnosis and Prevention Program.
-
- Aβ=
- β-amyloid;
- AD=
- Alzheimer disease;
- AIBL=
- Australian Imaging, Biomarkers and Lifestyle Study of Ageing;
- CAA=
- cerebral amyloid angiopathy;
- CAAH=
- CAA-associated hemorrhage;
- CDR=
- Clinical Dementia Rating;
- CI=
- confidence interval;
- HC=
- healthy controls;
- ICH=
- intracerebral hemorrhage;
- LMH=
- lobar microhemorrhage;
- MCI=
- mild cognitive impairment;
- MH=
- microhemorrhage;
- MMSE=
- Mini-Mental State Examination;
- OR=
- odds ratio;
- PiB=
- Pittsburgh compound B;
- SUVR=
- standardized uptake value ratio;
- SWI=
- susceptibility-weighted MRI
- Received December 9, 2010.
- Accepted March 1, 2011.
- Copyright © 2011 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
- Probing {beta}-amyloid in patients with cerebral microhemorrhage: what model to choose?
- Bart N van Berckel, Nuclear Medicine Physician, Departments of Nuclear Medicine & PET Research, Neurology; Alzheimer Center Amsterdam, VU UniversityB.Berckel@VUmc.nl
- W. van der Flier, R. Boellaard, P. Scheltens and A.A. Lammertsma
Submitted August 25, 2011
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.

